科望医药二次递表港交所:去年净亏收窄至8800万元,预计最早2028年商业化

澎湃新闻
30 May

近日,港交所官网显示,Elpiscience Biopharmaceuticals, Inc. (简称“科望医药”)递交招股书,这是该公司继2024年6月首次向港交所递表后,第二次冲刺港股上市。更早之前的2021年,科望医药还曾向美国证监会(SEC)提交上市申请,最终因估值等原因撤回申请。科望医药成立于2016年,总部位于苏州,是一家处于临床阶段的生物制药公司。其最为国内医药行业所知的是2023...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10